NasdaqGS - Nasdaq Real Time Price USD
Neurocrine Biosciences, Inc. (NBIX)
125.00
+0.44
+(0.35%)
At close: 4:00:00 PM EDT
124.91
-0.09
(-0.07%)
After hours: 6:02:11 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 360,110 | 45 |
Sales | 315,410 | 36 |
Net Shares Purchased (Sold) | 44,700 | 81 |
Total Insider Shares Held | 1.08M | -- |
% Net Shares Purchased (Sold) | 4.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
GORMAN KEVIN CHARLES Director | Sale at price 120.38 per share. | Direct | 1,157,211 | May 27, 2025 |
MERCIER JOHANNA Director | -- | Direct | -- | May 22, 2025 |
NORWALK LESLIE V Director | -- | Direct | -- | May 22, 2025 |
SHARP SHALINI Director | -- | Direct | -- | May 22, 2025 |
POON CHRISTINE A Director | -- | Direct | -- | May 22, 2025 |
LYONS GARY A Director | -- | Direct | -- | May 22, 2025 |
SHERWIN STEPHEN A Director | -- | Direct | -- | May 22, 2025 |
POPS RICHARD F Director | -- | Direct | -- | May 22, 2025 |
MORROW GEORGE J Director | -- | Direct | -- | May 22, 2025 |
RASTETTER WILLIAM H Director | -- | Direct | -- | May 22, 2025 |
COOKE JULIE SMITH Officer | Conversion of Exercise of derivative security at price 61.82 per share. | Direct | 399,852 | May 16, 2025 |
RASTETTER WILLIAM H Director | Sale at price 110.20 per share. | Indirect | 3,305,952 | May 5, 2025 |
RASTETTER WILLIAM H Director | Conversion of Exercise of derivative security at price 42.76 per share. | Indirect | 1,282,800 | May 5, 2025 |
ROBERTS EIRY WYN Officer | Sale at price 115.04 - 116.90 per share. | Direct | 258,264 | Feb 14, 2025 |
SHERWIN STEPHEN A Director | Sale at price 116.69 per share. | Direct | 1,613,923 | Feb 13, 2025 |
COOKE JULIE SMITH Officer | Sale at price 116.77 - 116.80 per share. | Direct | 181,129 | Feb 13, 2025 |
BOYER DAVID WARREN Officer | Sale at price 116.69 - 116.79 per share. | Direct | 208,387 | Feb 13, 2025 |
ONYIA JUDE Officer | Sale at price 116.75 - 116.83 per share. | Direct | 336,239 | Feb 13, 2025 |
DELAET INGRID Officer | Sale at price 116.69 - 116.72 per share. | Direct | 171,674 | Feb 13, 2025 |
GORMAN KEVIN CHARLES Director | Sale at price 116.68 - 116.69 per share. | Direct | 681,914 | Feb 13, 2025 |
ABERNETHY MATTHEW C Chief Financial Officer | Sale at price 116.85 - 116.87 per share. | Direct | 298,923 | Feb 13, 2025 |
GANO KYLE W Chief Executive Officer | Sale at price 116.84 - 116.86 per share. | Direct | 298,908 | Feb 13, 2025 |
BENEVICH ERIC S. Officer | Sale at price 116.71 - 116.74 per share. | Direct | 251,428 | Feb 13, 2025 |
LIPPOLDT DARIN M Officer | Sale at price 116.75 - 116.76 per share. | Direct | 254,992 | Feb 13, 2025 |
COOKE JULIE SMITH Officer | -- | Direct | -- | Feb 13, 2025 |
BOYER DAVID WARREN Officer | -- | Direct | -- | Feb 13, 2025 |
ONYIA JUDE Officer | -- | Direct | -- | Feb 13, 2025 |
DELAET INGRID Officer | -- | Direct | -- | Feb 13, 2025 |
LIPPOLDT DARIN M Officer | -- | Direct | -- | Feb 13, 2025 |
GANO KYLE W Chief Executive Officer | -- | Direct | -- | Feb 13, 2025 |
BENEVICH ERIC S. Officer | -- | Direct | -- | Feb 13, 2025 |
ABERNETHY MATTHEW C Chief Financial Officer | -- | Direct | -- | Feb 13, 2025 |
ROBERTS EIRY WYN Officer | -- | Direct | -- | Feb 13, 2025 |
GORMAN KEVIN CHARLES Director | -- | Direct | -- | Feb 13, 2025 |
LIPPOLDT DARIN M Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 12, 2025 |
COOKE JULIE SMITH Officer | Sale at price 118.28 per share. | Direct | 82,792 | Feb 10, 2025 |
BOYER DAVID WARREN Officer | Sale at price 118.31 per share. | Direct | 82,820 | Feb 10, 2025 |
GORMAN KEVIN CHARLES Director | Sale at price 118.37 per share. | Direct | 269,167 | Feb 10, 2025 |
ABERNETHY MATTHEW C Chief Financial Officer | Sale at price 118.27 per share. | Direct | 115,909 | Feb 10, 2025 |
ROBERTS EIRY WYN Officer | Sale at price 118.22 per share. | Direct | 115,853 | Feb 10, 2025 |
GANO KYLE W Chief Executive Officer | Sale at price 118.39 per share. | Direct | 116,020 | Feb 10, 2025 |
BENEVICH ERIC S. Officer | Sale at price 118.31 per share. | Direct | 115,940 | Feb 10, 2025 |
LIPPOLDT DARIN M Officer | Sale at price 118.25 per share. | Direct | 107,727 | Feb 10, 2025 |
COOKE JULIE SMITH Officer | -- | Direct | -- | Feb 7, 2025 |
BOYER DAVID WARREN Officer | -- | Direct | -- | Feb 7, 2025 |
LIPPOLDT DARIN M Officer | -- | Direct | -- | Feb 7, 2025 |
GANO KYLE W Chief Executive Officer | -- | Direct | -- | Feb 7, 2025 |
BENEVICH ERIC S. Officer | -- | Direct | -- | Feb 7, 2025 |
ABERNETHY MATTHEW C Chief Financial Officer | -- | Direct | -- | Feb 7, 2025 |
ROBERTS EIRY WYN Officer | -- | Direct | -- | Feb 7, 2025 |
Related Tickers
UTHR United Therapeutics Corporation
324.20
-0.39%
ALKS Alkermes plc
31.27
-0.06%
RDY Dr. Reddy's Laboratories Limited
14.66
-0.54%
KNSA Kiniksa Pharmaceuticals International, plc
29.11
+4.26%
ELAN Elanco Animal Health Incorporated
13.46
+0.30%
PCRX Pacira BioSciences, Inc.
26.40
+0.61%
DVAX Dynavax Technologies Corporation
10.01
+1.73%
HCM HUTCHMED (China) Limited
14.70
+8.09%
PBH Prestige Consumer Healthcare Inc.
84.87
-0.73%
AMPH Amphastar Pharmaceuticals, Inc.
26.01
+2.48%